The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickshVIVO Regulatory News (HVO)

Share Price Information for hVIVO (HVO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.25
Bid: 28.00
Ask: 28.50
Change: 0.25 (0.89%)
Spread: 0.50 (1.786%)
Open: 28.25
High: 28.25
Low: 28.25
Prev. Close: 28.00
HVO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

6 Apr 2023 15:54

RNS Number : 6840V
hVIVO PLC
06 April 2023
 

The Company has received the below TR-1 from Cathal Friel. As a result of an increase in the Company's share capital Mr Friel's percentage holding has now fallen from 7.02% to 6.94% of the total issued share capital. However, Mr Friel's total shareholding remains unchanged at 47,087,086 Ordinary Shares.

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

hVIVO plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

X

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Cathal Friel

City and country of registered office (if applicable)

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

28/03/2023

6. Date on which issuer notified (DD/MM/YYYY):

06/04/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuervii

Resulting situation on the date on which threshold was crossed or reached

6.94%

N/A

6.94%

47,087,086

Position of previous notification (if

applicable)

7.02%

N/A

7.02%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00B9275X97

47,087,086

6.94%

SUBTOTAL 8. A

47,087,086

6.94%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

NamexvCh

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Dublin

Date of completion

06/04/2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLIFMITMTAMBTJ
Date   Source Headline
9th Feb 20177:00 amRNSData from PrEP Biopharm's Ph. IIa clinical studies
5th Jan 20177:00 amRNSDirectors' Dealings
30th Dec 20167:00 amRNSChange of auditor
27th Oct 20167:00 amRNSNotification of Major Interest in Shares
12th Oct 20167:00 amRNSDirectors' Dealings
23rd Sep 20167:00 amRNSExercise of Share Options
22nd Sep 20167:00 amRNSHalf-year Report
21st Sep 20167:00 amRNSTrading Update
8th Sep 20167:00 amRNSNotification of Major Interest in Shares
2nd Sep 20167:00 amRNShVIVO Landmark Asthma Study Underway
4th Aug 20167:00 amRNSDirectors' Dealings
12th Jul 201612:45 pmRNSNotification of Major Interest in Shares
14th Jun 201612:00 pmRNSFavourable results for PrEP Biopharm's Flu Study
24th May 20167:00 amRNSDavid Norwood Lock-in Deed
23rd May 201612:00 pmRNSResult of AGM
28th Apr 20162:05 pmRNS2015 Annual Report and Financial Statements
27th Apr 20167:00 amRNSNotification of Major Interest in Shares
25th Apr 20167:00 amRNSInitial results for PrEP Biopharm's Flu study
22nd Apr 20167:00 amRNSJoint Venture Investment with the SEEK Group
21st Apr 201611:43 amRNSNotification of Major Interest in Shares
20th Apr 20167:01 amRNSBoard Changes
20th Apr 20167:00 amRNS2015 Audited Preliminary Results
14th Apr 20167:00 amRNSDirectors' Dealings
16th Mar 20169:32 amRNSNotification of Major Interest in Shares
6th Jan 20167:00 amRNSDirectors' Dealings
18th Dec 20157:00 amRNSNotification of Major Interest in Shares
17th Dec 20152:00 pmRNSNotification of Major Interest in Shares
17th Dec 20157:00 amRNSNotification of Major Interest in Shares
15th Dec 20152:00 pmRNSResult of General Meeting
30th Nov 20157:00 amRNSNotification of Major Interest in Shares
26th Nov 20157:00 amRNSConditional Placing to raise £20.5 million
2nd Nov 20157:01 amRNSTrading Update
2nd Nov 20157:00 amRNShVIVO invests in PrEP Biopharm Limited
5th Oct 20152:00 pmRNSDirectors' Dealings
24th Sep 20157:00 amRNSHalf Yearly Report
6th Jul 20157:00 amRNSDirectors' Dealings
25th Jun 20152:00 pmRNSExercise of Share Options
8th Jun 20154:35 pmRNSPrice Monitoring Extension
4th Jun 20154:40 pmRNSSecond Price Monitoring Extn
4th Jun 20154:35 pmRNSPrice Monitoring Extension
29th May 20157:00 amRNSNotification of Major Interest in Shares
26th May 201512:00 pmRNSResult of AGM
14th May 20157:00 amRNSDirector's Dealings
13th May 20157:00 amRNSExercise of Share Options
8th May 20157:00 amRNSDirector's Dealings
30th Apr 20156:26 pmRNSDirector's Dealings
24th Apr 20152:00 pmRNS2014 Annual Report and Financial Statements
21st Apr 20153:43 pmRNSAward of Share Options
16th Apr 20157:01 amRNS2014 Audited Preliminary Results
16th Apr 20157:00 amRNSConfirmation of Change of Name to hVIVO plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.